These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 20074451)
1. Decrease in phosphorylation of ERK following decreased expression of NK cell-activating receptors in human NK cell line exposed to asbestos. Nishimura Y; Maeda M; Kumagai N; Hayashi H; Miura Y; Otsuki T Int J Immunopathol Pharmacol; 2009; 22(4):879-88. PubMed ID: 20074451 [TBL] [Abstract][Full Text] [Related]
2. Impairment in cytotoxicity and expression of NK cell- activating receptors on human NK cells following exposure to asbestos fibers. Nishimura Y; Miura Y; Maeda M; Kumagai N; Murakami S; Hayashi H; Fukuoka K; Nakano T; Otsuki T Int J Immunopathol Pharmacol; 2009; 22(3):579-90. PubMed ID: 19822075 [TBL] [Abstract][Full Text] [Related]
3. Suppressive effect of asbestos on cytotoxicity of human NK cells. Nishimura Y; Kumagai N; Maeda M; Hayashi H; Fukuoka K; Nakano T; Miura Y; Hiratsuka J; Otsuki T Int J Immunopathol Pharmacol; 2011; 24(1 Suppl):5S-10S. PubMed ID: 21329559 [TBL] [Abstract][Full Text] [Related]
4. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways. Chuang SS; Kumaresan PR; Mathew PA J Immunol; 2001 Dec; 167(11):6210-6. PubMed ID: 11714782 [TBL] [Abstract][Full Text] [Related]
6. NK cell function triggered by multiple activating receptors is negatively regulated by glycogen synthase kinase-3β. Kwon HJ; Kwon SJ; Lee H; Park HR; Choi GE; Kang SW; Kwon SW; Kim N; Lee SY; Ryu S; Kim SC; Kim HS Cell Signal; 2015 Sep; 27(9):1731-41. PubMed ID: 26022178 [TBL] [Abstract][Full Text] [Related]
7. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Kubin M; Cosman D J Immunol; 2002 Jan; 168(2):671-9. PubMed ID: 11777960 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation. Zhang C; Zhang J; Niu J; Zhang J; Tian Z Cytokine; 2008 Apr; 42(1):128-36. PubMed ID: 18280748 [TBL] [Abstract][Full Text] [Related]
9. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. Sun C; Fu B; Gao Y; Liao X; Sun R; Tian Z; Wei H PLoS Pathog; 2012; 8(3):e1002594. PubMed ID: 22438812 [TBL] [Abstract][Full Text] [Related]
10. Recruitment of activating NK-cell receptors 2B4 and NKG2D to membrane microdomains in mammalian cells is dependent on their transmembrane regions. Gütgemann SA; Sandusky MM; Wingert S; Claus M; Watzl C Eur J Immunol; 2015 Apr; 45(4):1258-69. PubMed ID: 25545687 [TBL] [Abstract][Full Text] [Related]
11. IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway. Song H; Park H; Kim J; Park G; Kim YS; Kim SM; Kim D; Seo SK; Lee HK; Cho D; Hur D Immunol Lett; 2011 May; 136(2):187-93. PubMed ID: 21277902 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol enhances perforin expression and NK cell cytotoxicity through NKG2D-dependent pathways. Lu CC; Chen JK J Cell Physiol; 2010 May; 223(2):343-51. PubMed ID: 20082299 [TBL] [Abstract][Full Text] [Related]
13. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells. Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177 [TBL] [Abstract][Full Text] [Related]
14. Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions. Garcia-Iglesias T; Del Toro-Arreola A; Albarran-Somoza B; Del Toro-Arreola S; Sanchez-Hernandez PE; Ramirez-Dueñas MG; Balderas-Peña LM; Bravo-Cuellar A; Ortiz-Lazareno PC; Daneri-Navarro A BMC Cancer; 2009 Jun; 9():186. PubMed ID: 19531227 [TBL] [Abstract][Full Text] [Related]
15. Role for glycogen synthase kinase-3 in NK cell cytotoxicity and X-linked lymphoproliferative disease. Aoukaty A; Tan R J Immunol; 2005 Apr; 174(8):4551-8. PubMed ID: 15814676 [TBL] [Abstract][Full Text] [Related]
16. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells. Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997 [TBL] [Abstract][Full Text] [Related]
17. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104. Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142 [TBL] [Abstract][Full Text] [Related]
18. Functional role of human NK cell receptor 2B4 (CD244) isoforms. Mathew SO; Rao KK; Kim JR; Bambard ND; Mathew PA Eur J Immunol; 2009 Jun; 39(6):1632-41. PubMed ID: 19499526 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase C is involved in 2B4 (CD244)-mediated cytotoxicity and AP-1 activation in natural killer cells. Chuang SS; Lee JK; Mathew PA Immunology; 2003 Jul; 109(3):432-9. PubMed ID: 12807490 [TBL] [Abstract][Full Text] [Related]
20. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase. Aoukaty A; Tan R J Biol Chem; 2002 Apr; 277(15):13331-7. PubMed ID: 11815622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]